Chest
Translating Basic Research into Clinical PracticeAirway Inflammation in Cystic Fibrosis
Section snippets
Effects of Airway Inflammation in the CF Lung
With the exception of plugging and distension of submucosal gland ducts, the lungs of newborn infants with CF are structurally normal. Moreover, bacterial cultures of respiratory secretions from infants with CF often fail to yield a specific pathogen. Over time, however, bacteria chronically infect the airways and incite intense inflammation. Respiratory secretions from CF patients often have high concentrations of neutrophils, cytokines, and chemokines, even in young children or adults who
Inflammation Independent of Infection in the CF Airway
Chronic bacterial infection is undoubtedly the leading cause for progressive neutrophilic inflammation in patients with CF. The preponderance of evidence suggests that the airway inflammation is initiated and sustained by infection. CF bronchial epithelial cells grown in culture have little nuclear factor (NF)-κB activation or IL-8 production in the absence of an inflammatory stimulus,8 and CF infants and age-matched control subjects have similar BAL fluid profiles of proinflammatory cytokines.9
CF Airway Inflammation Disproportionate to Infection
Several lines of evidence have indicated that inflammation in CF airways is excessive and sustained relative to the infectious stimulus. In vitro models of CF respiratory epithelial cells have indeed demonstrated the increased release of inflammatory mediators after exposure to inflammatory stimuli compared to cells expressing a normal CFTR, possibly mediated through dysregulation of the transcription factor NF-κB.11 Excessive inflammation may also result from impaired inflammatory control such
Clinical Measurement of CF Airway Inflammation
Treatments are currently being developed to minimize the deleterious effects of the neutrophil without impairing host defenses against infection, since they are certainly involved in containing infection within the lung. To achieve this goal, sensitive outcome measures are needed to evaluate the efficacy of antiinflammatory therapies.
The most frequently used, albeit indirect, outcome measures in studies examining the effectiveness of antiinflammatory agents in CF patients are lung function
Treatment of CF Airway Inflammation
Given that chronic bacterial infection leads to airway inflammation, antibiotic therapy, which is the mainstay in CF care, decreases the inflammatory response by decreasing its primary stimulus. In addition, therapies attempting to treat the inflammatory response directly have been used over the years with variable success.
Several studies27 have reported the beneficial effects of systemic corticosteroids in the treatment of CF patients, especially in those children who have mild lung disease.
Summary
Pulmonary inflammation contributes significantly to morbidity and mortality in CF patients. This inflammatory response may be exaggerated compared to the response of the non-CF respiratory epithelium to similar infectious stimuli, or may even be present in the absence of infection. Even if the inflammatory response of CF respiratory epithelial cells is proportional to the stimulus, the response to the chronic endobronchial infections is ultimately deleterious. Consequently, pulmonary
ACKNOWLEDGMENT
The authors thank Albert Faro, Robert Strunk, and Jeffrey Atkinson for their critical reviews of the manuscript.
References (31)
- et al.
Altered respiratory epithelial cell cytokine production in cystic fibrosis
J Allergy Clin Immunol
(1999) - et al.
Viral respiratory infections in cystic fibrosis
J Cyst Fibros
(2005) - et al.
Cystic fibrosis
Am J Respir Crit Care Med
(1996) - et al.
Mucus clearance and lung function in cystic fibrosis with hypertonic saline
N Engl J Med
(2006) - et al.
Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-α and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis
J Immunol
(2005) - et al.
Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients
Am J Physiol Lung Cell Mol Physiol
(2007) - et al.
Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch
J Clin Invest
(1990) - et al.
Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis
Am J Respir Crit Care Med
(2004) - et al.
Exaggerated activation of nuclear factor-κB and altered IκB-β processing in cystic fibrosis bronchial epithelial cells
Am J Respir Cell Mol Biol
(2000) - et al.
Lower airway inflammation in infants with cystic fibrosis detected by newborn screening
Pediatr Pulmonol
(2005)
Activation of NF-κB in airway epithelial cells is dependent on CFTR trafficking and Cl- channel function
Am J Physiol Lung Cell Mol Physiol
Primary inflammation in human cystic fibrosis small airways
Am J Physiol Lung Cell Mol Physiol
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis
Pediatr Pulmonol
Interleukin-8 production by cystic fibrosis nasal epithelial cells after tumor necrosis factor-α and respiratory syncycial virus stimulation
Am J Respir Cell Mol Biol
Inflammatory response in isolated airway epithelial cells from patients with cystic fibrosis
Am J Respir Crit Care Med
Cited by (0)
The authors were supported by National Institutes of Health grants AI067856 (Dr. Cannon), HL64044 (Dr. Ferkol), and HL08265 (Dr. Ferkol), and by the March of Dimes (Dr. Ferkol).
The authors have reported to the ACCP that no significant conflicts of interest exist with any companies/organizations whose products or services may be discussed in this article.